Epicore BioNetworks IncTSXV: EBN

Epicore BioNetworks Inc. Announces Corporate Actions

· Issued by Epicore BioNetworks Inc via CNW

CALGARY, Feb. 3 /CNW/ - Epicore BioNetworks Inc. announces the retirement of Jean C. Messier as a director of the corporation. Mr. Messier has served the Board faithfully and diligently for nine years and his support and guidance helped Epicore evolve from a struggling startup to a successful enterprise. With his extensive sales and marketing expertise, Mr. Messier made numerous contributions to Epicore's business plans throughout the years. The Board wishes him the best in his retirement years.

Additionally, Epicore BioNetworks Inc. announces it has granted stock options to directors, pursuant to the Company's director compensation plan, to an officer and to employees of the company. The number of options granted is 350,000, which is equivalent to 1.5% of Epicore's issued common stock. Under the terms of the Epicore Stock Option Plan, options may be issued from time to time in any amount up to a maximum of 4,704,247 Epicore common shares. These options have an exercise price of Cdn $0.10 and expire in five years. Included in the grant are 100,000 share options to the Chief Financial Officer.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)

This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements. Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development. We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized. We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.

Epicore BioNetworks Inc on 6ix

Earlier from Epicore BioNetworks

Later from Epicore BioNetworks

All Epicore BioNetworks news releases